Phase Separation in Kidney Diseases: Autosomal Dominant Polycystic Kidney Disease and Beyond

被引:2
|
作者
Zhang, Lirong [1 ]
Liu, Zhiheng [1 ]
Lu, Yumei [1 ]
Nie, Jing [2 ,3 ]
Chen, Yupeng [1 ,4 ]
机构
[1] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Prov & Minist Cosponsored Collaborat Innovat Ctr, Tianjin, Peoples R China
[2] Southern Med Univ, Nanfang Hosp, Guangdong Prov Inst Nephrol, Natl Clin Res Ctr Kidney Dis,State Key Lab Organ, Guangzhou, Peoples R China
[3] Southern Med Univ, Nanfang Hosp, Div Nephrol, North Guangzhou Ave 1838, Guangzhou 510515, Peoples R China
[4] Tianjin Med Univ, Dept Biochem & Mol Biol, 22 Qixiangtai Rd, Tianjin 300070, Peoples R China
关键词
Phase separation; Autosomal dominant polycystic kidney disease; Metabolism; Epigenetics; Kidney diseases; LIQUID; TRANSITION; PROMOTES; GRANULE; SWITCH;
D O I
10.1159/000530250
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: The formation of biomolecular condensates via phase separation has emerged as a fundamental principle underlying the spatiotemporal coordination of biological activities in cells. Aberrant biomolecular condensates often directly regulate key cellular process involved in the pathogenesis of human diseases, including kidney diseases. Summary: In this review, we summarize the physiological roles of phase separation and methodologies for phase separation studies. Taking autosomal dominant polycystic kidney disease as an example, we discuss recent advances toward elucidating the multiple mechanisms involved in kidney pathology arising from aberrant phase separation. We suggest that dysregulation of phase separation contributes to the pathogenesis of other important kidney diseases, including kidney injury and fibrosis. Key Messages: Phase separation provides a useful new concept to understand the mechanisms underlying kidney disease development. Targeting aberrant phase-separated condensates offers new therapeutic avenues for combating kidney diseases.
引用
收藏
页码:229 / 238
页数:10
相关论文
共 50 条
  • [31] Extrarenal Manifestations of Autosomal Dominant Polycystic Kidney Disease
    Pirson, Yves
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (02) : 173 - 180
  • [32] Research on autosomal dominant polycystic kidney disease in China
    DAI Bing and MEI Chang-lin Division of Nephrology
    中华医学杂志(英文版), 2006, (22) : 1915 - 1924
  • [33] The pathogenesis of hypertension in autosomal dominant polycystic kidney disease
    Wang, D
    Strandgaard, S
    JOURNAL OF HYPERTENSION, 1997, 15 (09) : 925 - 933
  • [34] Ectopic (pelvic) Autosomal Dominant Polycystic Kidney Disease
    Chen, Dong-ping
    Ma, Yi-yi
    Mao, Zhi-guo
    Mei, Chang-lin
    INTERNAL MEDICINE, 2010, 49 (22) : 2525 - 2526
  • [35] Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease
    Hannah A. Blair
    Gillian M. Keating
    Drugs, 2015, 75 : 1797 - 1806
  • [36] Cardiovascular Complications in Autosomal Dominant Polycystic Kidney Disease
    Ecder, Tevfik
    CURRENT HYPERTENSION REVIEWS, 2013, 9 (01) : 2 - 11
  • [37] An update on tolvaptan for autosomal dominant polycystic kidney disease
    Poch, E.
    Rodas, L.
    Blasco, M.
    Molina, A.
    Quintana, L.
    DRUGS OF TODAY, 2018, 54 (09) : 519 - 533
  • [38] Targeted Therapies for Autosomal Dominant Polycystic Kidney Disease
    Stayner, Cherie
    Brooke, Darby G.
    Bates, Michael
    Eccles, Michael R.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (17) : 3081 - 3102
  • [39] Umbilical hernia in autosomal dominant polycystic kidney disease
    Hattori, Yoshinari
    Hoshino, Junichi
    Suwabe, Tatsuya
    Sumida, Keiichi
    Mise, Koki
    Hayami, Noriko
    Sawa, Naoki
    Takaichi, Kenmei
    Ubara, Yoshifumi
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2015, 19 (01) : 154 - 156
  • [40] Soluble Klotho and Autosomal Dominant Polycystic Kidney Disease
    Pavik, Ivana
    Jaeger, Philippe
    Ebner, Lena
    Poster, Diane
    Krauer, Fabienne
    Kistler, Andreas D.
    Rentsch, Katharina
    Andreisek, Gustav
    Wagner, Carsten A.
    Devuyst, Olivier
    Wuethrich, Rudolf P.
    Schmid, Christoph
    Serra, Andreas L.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (02): : 248 - 257